Skip to main content

C209 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)

Pill with imprint C209 is Blue, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Cipla USA, Inc.

Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C209

Emtricitabine and tenofovir disoproxil fumarate 200 mg / 300 mg C209

Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
C209
Strength
200 mg / 300 mg
Color
Blue
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
Appco Pharma LLC
National Drug Code (NDC)
69097-0209

Get help with Imprint Code FAQs.

Related images for "C209"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.